In an open briefing on 2 May 2007 MD & CEO Graham Liebelt ended with the following:
"But, you can infer from the fact that the board has rejected an offer for the company at $32.00 per share that we still see good value in our shares at that price level."
With the SP now more than 16% off that mark is this a statement he might look back on and say "Er, well."
- Forums
- ASX - By Stock
- ORI
- big statement
ORI
orica limited
Add to My Watchlist
0.21%
!
$19.18

big statement
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$19.18 |
Change
-0.040(0.21%) |
Mkt cap ! $9.259B |
Open | High | Low | Value | Volume |
$19.21 | $19.33 | $19.11 | $3.859M | 200.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 119 | $19.18 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.19 | 2324 | 34 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
21 | 1690 | 19.180 |
25 | 2228 | 19.170 |
14 | 1848 | 19.160 |
12 | 1953 | 19.150 |
9 | 1575 | 19.140 |
Price($) | Vol. | No. |
---|---|---|
19.190 | 2279 | 28 |
19.200 | 1893 | 18 |
19.210 | 1984 | 21 |
19.220 | 2983 | 14 |
19.230 | 2309 | 9 |
Last trade - 12.49pm 18/06/2025 (20 minute delay) ? |
Featured News
ORI (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
SPONSORED BY The Market Online